Last updated 2026-08-10
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
Pre-Seed, Seed, Series A, Growth
About
Yair Geva is a prominent figure in the Israeli tech ecosystem, known for his roles as a tech investor and as the head of the Startups and Emerging Companies Group at Herzog, one of Israel's largest law firms. He is a New York and Israeli corporate transactional lawyer with extensive experience in cross-border mergers and acquisitions, private equity, and venture capital investments. Geva advises numerous Israeli startups and growth companies across various industries, including e-commerce, cyber, fintech, blockchain & web3, crypto, clean energy, and biotech.
Portfolio
No portfolio companies in this dataset yet.
Q&A
- What is Yair Geva's primary role in the Israeli tech ecosystem?
- Yair Geva is an Israeli tech investor and a partner and head of the Tech Division at Herzog, a leading Israeli law firm.
- What investment stages does Yair Geva typically focus on?
- Yair Geva focuses on Pre-Seed, Seed, Series A, and Growth stage investments.
- What are some of the preferred sectors for Yair Geva's investments?
- Yair Geva's preferred sectors include e-commerce, cyber, fintech, blockchain & web3, crypto, clean energy, biotech, digital health, and AI.
- In which geographies does Yair Geva prefer to invest?
- Yair Geva prefers to invest in Israel and the US.
- What kind of support does Yair Geva provide to portfolio companies?
- Yair Geva provides capital and strategic support, including mentorship, networking opportunities, and domain-specific guidance, to foster innovation and advance AI technologies.
- What is Yair Geva's professional background?
- Yair Geva is a New York and Israeli corporate transactional lawyer with extensive experience in cross-border mergers and acquisitions, private equity, and venture capital investments.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 13 |
|---|